Garbriel Afram

5PUBLICATIONS
12CO-AUTHORS
Aboriginal and Torres Strait Islander repatriationCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 27, 2022
Response to Caravita di Toritto and Rago.

Roza Chaireti, Katarina Uttervall, Vincent Luong

|Sep 06, 2022
Conditioning with melphalan 200 mg/m<sup>2</sup> and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.

Gabriel Afram, Roza Chaireti, Katarina Uttervall

|Jan 20, 2021
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups.

Gabriel Afram, Katharina Helene Susek, Katarina Uttervall

|Apr 14, 2020
Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real-life outcomes of daratumumab treatment.

Garbriel Afram, Charlotte Gran, Johanna Borg Bruchfeld

|Apr 27, 2018
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting.

Gabriel Afram, Jose Antonio Pérez Simón, Mats Remberger

Pageof 1

Frequent Collaborators

2 joint publications

Arnika Kathleen Wagner

2 joint publications

Roza Chaireti

1 joint publications

Katharina Helene Susek

1 joint publications

Katarina Uttervall